Exposure‐safety and exposure‐efficacy analyses for tisotumab vedotin for patients with locally advanced or metastatic solid tumors

Abstract The antibody‐drug conjugate (ADC) tisotumab vedotin (TV) received accelerated approval from the US Food and Drug Administration for treatment of adults with recurrent or metastatic cervical cancer (r/mCC) with disease progression on or after chemotherapy. A population pharmacokinetic (PK) m...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Chaitali Passey (Author), Jenna Voellinger (Author), Leonid Gibiansky (Author), Rudy Gunawan (Author), Leonardo Nicacio (Author), Ibrahima Soumaoro (Author), William D. Hanley (Author), Helen Winter (Author), Manish Gupta (Author)
Formato: Libro
Publicado: Wiley, 2023-09-01T00:00:00Z.
Subjects:
Acceso en liña:Connect to this object online.
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Internet

Connect to this object online.

3rd Floor Main Library

Detalle de Existencias desde 3rd Floor Main Library
Número de Clasificación: A1234.567
Copia 1 Dispoñible